A new study explores the relationship between hypoglycemia, cardiovascular outcomes, and treatment with an SGLT2 inhibitor. Might an SGLT2 inhibitor offer a cardio-protective effect?
European Heart Journal
Original Article: A New Perspective on Lowering CV Risk From Hypoglycemia